Molnupiravir

U.S. health advisers have endorsed an antiviral drug from Merck to treat COVID-19.

Britain has granted a conditional authorization to Merck’s coronavirus antiviral

Drugmaker Merck has asked U.S. regulators to authorize its promising antiviral pill against COVID-19, setting the stage for a decision within weeks